Holly B. Kordasiewicz, EVP, Chief Development Officer at Ionis Pharmaceuticals, sold IONS on Jun 12, 2026
Data as of Oct 16
▼ SELL$3M41,004 shares at $73.09Holly B. Kordasiewicz EVP, Chief Development OfficerIONS Ionis Pharmaceuticals Inc
- Traded
- Jun 12, 2026
- Disclosed
- Jun 16, 2026
- Filed
- 4 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
IONS since disclosure
−41.3%
after the sale
Similar stocks (XLV) since disclosure
+15.5%
XLV — its sector index fund
Change in closing price from Jun 16, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLHolly B. Kordasiewicz EVP, Chief Development OfficerIONS Ionis Pharmaceuticals Inc$1.5Mdisclosed Jun 16 · filed 4 days after the trade